Global single-use bioprocessing market was valued at USD 15.8 Billion in 2020. It is projected to grow at a compound annual rate (CAGR), of 16.0% between 2021 and 2028. The advantages of Single-Use Technology (SUT) such as significant cost reductions and shorter construction times have led to a rise in disposables being used in the bioprocessing sector. This has led to a double-digit increase in single-use bioprocessing market.
The market also experienced significant growth despite the economic losses caused by the COVID-19 pandemic. Many CMOs and biomanufacturers have switched their business focus to producing therapeutics against SARS/CoV-2 infection using disposable technology. Serum Institute chose ABEC's Custom Single Run technology (CSR), in September 2020 to speed up large-scale single-use production of Novavax vaccine, which is intended against COVID-19.
Single-use Systems (SUS), are a viable commercial option to maximize process efficiency and productivity for multiple end-users. SUS equipment is widely used in biomanufacturing, especially pre-commercial biopharmaceutical manufacturing. This has opened up new opportunities for product suppliers in this space.
The market for single-use bioprocessing is also being driven by the increasing number of vendors that offer robust disposables for commercial production of biopharmaceuticals. Automation has also facilitated exponential growth in biomanufacturing efficiency. In the near future, big data analytics will be a major trend.
Big data machine-learning analytical models are expected to improve product yields and enable prediction. CMOs are more likely to use disposables than ever before because of the ease and efficiency of SUTs in bioprocessing multiple products that require quick turnaround times.
In 2020, the market for single-use Bioprocessing was dominated by the simple and peripheral components segment. This segment had a 49.0% revenue share and accounted for the majority of the market's overall revenues. This segment has seen the highest adoption of connectors, tubing, transfer system, filters and tubing in terms of product availability. Bioprocess engineers have been able to replace their fixed pipes networks with single-use transfer line designs thanks to advances in single-use systems.
Single-use bags are also more reproducible because they can be used for multiple purposes. They can be strong, durable, and resistant to temperature changes. Market players can tap into untapped markets by having disposable bioprocess bags available in different sizes and for multiple applications.
The demand for disposable probes is growing in the biopharmaceutical sector. The demand for disposable probes and sensors is high in the U.S. as well as Europe. Small and emerging players are working to gain a competitive advantage in this market by providing single-use sensors that can measure multiple attributes during bioprocessing.
In 2020, the largest revenue share was 57.0% for the upstream workflow segment in single-use bioprocessing. Single-use systems are more common for upstream processing than downstream. They can be used for media preparation, cell culture seeding, aseptic sampling and other tasks. The increasing demand for disposable bioprocess applications has led to industrial suppliers of SUSs to focus on providing advanced products that can overcome productivity issues.
SUT suppliers are making rapid progress in implementing disposables in downstream processing. The segment's growth is being accelerated by the introduction of disposable units for downstream processing, such as pre-packed columns, filtration devices and pumps.
In 2020, the biopharmaceutical manufacturers market dominated single-use bioprocessing. They accounted for more than 58.0% of the total revenue. Biopharmaceutical manufacturing has greatly benefited from the growing popularity of disposables among contract manufacturers. Many biomanufacturers are investing in new disposable equipment and expanding their manufacturing capabilities to meet changing customer needs.
The COVID-19 pandemic, which has increased investment in the bioprocessing sector, has also boosted single-use bioprocessing. To meet market demand, market players have invested a large amount of money to create single-use products like smart connected temperature sensors. In the future, growth is expected to be strong for academic and clinical research institutions.
The market for single-use bioprocessing is expected to benefit from the expansion of clinical research activities that will help to determine the potential of biotherapeutics to treat various diseases. The segment is also being boosted by the presence of institutes like the National Institute for Bioprocessing Research and Training, which provides training and research expertise for bioprocessing industries.
North America was the dominant single-use market for bioprocessing in 2020 with a 33.5% revenue share. The dominance of this region is due to its expanding biopharmaceutical R&D and large-scale biopharmaceutical manufacturing plants in the U.S. Many contract manufacturing companies in North America are involved in the use of disposables in their production processes.
This trend has led to increased investments in this market. Fujifilm Diosynth, for example, invested USD 2Billion in the U.S. to produce large-scale cell cultures in January 2021. The site will house eight bioreactors of 20,000 liters. China is a market that has been growing in biopharmaceutical manufacturing and single-use technology.
Wuxi Biologics, one of China's most important CDMOs, is located in China. The company began GMP-compliant operations in China's China facility in February 2021. The facility is equipped with nine single-use, 4,000-liter bioreactors. This region will see the fastest CAGR with India and China at the forefront during the forecast period.
Sartorius AG is a market leader due to its extensive product range and large customer base. The market position of Danaher, which acquired GE Healthcare's Biopharma business from GE Healthcare, has been boosted by the acquisition. Danaher Corporation purchased GE Healthcare's Biopharma business in March 2020 for USD 20 billion net cash. Cytiva is now the name of the biopharma unit.
OEMs are also actively involved in expanding their products to secure a strong revenue share of single-use bioprocessing. Thermo Fisher Scientific's HyPerforma DynaDrive Single Use Bioreactor (SUB), was introduced in December 2020. It offers improved performance and scalability. This product is ideal for large-scale cell cultivation processes. The market leader in single-use bioprocessing is:
Thermo Fisher Scientific, Inc.
Merck KGaA
Sartorius AG
Corning Incorporated
Pall Corporation
General Electric Company (GE Healthcare).
Eppendorf AG
Rentschler Biopharma SE
Lonza
Meissner Filtration Products, Inc.
JM BioConnect
Boehringer Ingelheim GmbH
Infors AG
PBS Biotech, Inc.
Entegris, Inc.
Danaher Corporation
Kuhner AG
Rentschler Biopharma SE
Up Market Research published a new report titled “Single-use Bioprocessing Market research report which is segmented by Workflow (Upstream, Downstream), by Product (Simple & Peripheral Elements, Probes & Sensors), By Players/Companies Meissner Filtration Products Inc, Danaher Corporation, Pall Corporation, Boehringer Ingelheim GmbH, PBS Biotech Inc, Kuhner AG, Entegris Inc, Thermo Fisher Scientific Inc, Infors AG, Lonza, JM BioConnect, Corning Incorporated, Sartorius AG, Rentschler Biopharma SE, Rentschler Biopharma SE, Eppendorf AG, General Electric Company (GE Healthcare), Merck KGaA”. As per the study the market is expected to grow at a CAGR of XX% in the forecast period.
Report Attributes | Report Details |
Report Title | Single-use Bioprocessing Market Research Report |
By Workflow | Upstream, Downstream |
By Product | Simple & Peripheral Elements, Probes & Sensors |
By Companies | Meissner Filtration Products Inc, Danaher Corporation, Pall Corporation, Boehringer Ingelheim GmbH, PBS Biotech Inc, Kuhner AG, Entegris Inc, Thermo Fisher Scientific Inc, Infors AG, Lonza, JM BioConnect, Corning Incorporated, Sartorius AG, Rentschler Biopharma SE, Rentschler Biopharma SE, Eppendorf AG, General Electric Company (GE Healthcare), Merck KGaA |
Regions Covered | North America, Europe, APAC, Latin America, MEA |
Base Year | 2020 |
Historical Year | 2018 to 2019 (Data from 2010 can be provided as per availability) |
Forecast Year | 2028 |
Number of Pages | 221 |
Number of Tables & Figures | 155 |
Customization Available | Yes, the report can be customized as per your need. |
The report covers comprehensive data on emerging trends, market drivers, growth opportunities, and restraints that can change the market dynamics of the industry. It provides an in-depth analysis of the market segments which include products, applications, and competitor analysis.
The market is segmented by Workflow (Upstream, Downstream), by Product (Simple & Peripheral Elements, Probes & Sensors).
Single-use Bioprocessing Market research report delivers a close watch on leading competitors with strategic analysis, micro and macro market trend and scenarios, pricing analysis and a holistic overview of the market situations in the forecast period. It is a professional and a detailed report focusing on primary and secondary drivers, market share, leading segments and geographical analysis. Further, key players, major collaborations, merger & acquisitions along with trending innovation and business policies are reviewed in the report.
Key Benefits for Industry Participants & Stakeholders:
Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa (MEA). North America region is further bifurcated into countries such as U.S., and Canada. The Europe region is further categorized into U.K., France, Germany, Italy, Spain, Russia, and Rest of Europe. Asia Pacific is further segmented into China, Japan, South Korea, India, Australia, South East Asia, and Rest of Asia Pacific. Latin America region is further segmented into Brazil, Mexico, and Rest of Latin America, and the MEA region is further divided into GCC, Turkey, South Africa, and Rest of MEA.
We have studied the Single-use Bioprocessing Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2028.
How you may use our products:
Reasons to Purchase the Single-use Bioprocessing Market Report:
Some other reports from this category!